Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Parveen, Amna | - |
dc.contributor.author | Subedi, Lalita | - |
dc.contributor.author | Kim, Heung Wan | - |
dc.contributor.author | Khan, Zahra | - |
dc.contributor.author | Zahra, Zahra | - |
dc.contributor.author | Farooqi, Muhammad Qudratullah | - |
dc.contributor.author | Kim, Sun Yeou | - |
dc.date.available | 2020-02-27T03:43:17Z | - |
dc.date.created | 2020-02-04 | - |
dc.date.issued | 2019-03 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1728 | - |
dc.description.abstract | The role of vascular endothelial growth factor (VEGF) in cancer cells is not limited to angiogenesis; there are also multiple factors, such as neuropilins (non-tyrosine kinases receptors), tyrosine kinases receptors, immunodeficiencies, and integrins, that interact with VEGF signaling and cause cancer initiation. By combating these factors, tumor progression can be inhibited or limited. Natural products are sources of several bioactive phytochemicals that can interact with VEGF-promoting factors and inhibit them through various signaling pathways, thereby inhibiting cancer growth. This review provides a deeper understanding of the relation and interaction of VEGF with cancer-promoting factors and phytochemicals in order to develop multi-targeted cancer prevention and treatment. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL MEDICINE | - |
dc.title | Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000464437500002 | - |
dc.identifier.doi | 10.3390/jcm8030350 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL MEDICINE, v.8, no.3 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85065453000 | - |
dc.citation.title | JOURNAL OF CLINICAL MEDICINE | - |
dc.citation.volume | 8 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | Parveen, Amna | - |
dc.contributor.affiliatedAuthor | Kim, Heung Wan | - |
dc.contributor.affiliatedAuthor | Khan, Zahra | - |
dc.contributor.affiliatedAuthor | Kim, Sun Yeou | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | vascular endothelial growth factor | - |
dc.subject.keywordAuthor | receptor tyrosine kinases | - |
dc.subject.keywordAuthor | neuropilins | - |
dc.subject.keywordAuthor | epithelial-mesenchymal transition | - |
dc.subject.keywordAuthor | hypoxia-inducible factor | - |
dc.subject.keywordAuthor | estrogen receptor-beta | - |
dc.subject.keywordAuthor | prolyl hydroxylase 2 | - |
dc.subject.keywordAuthor | Notch ligand Delta-like 4 | - |
dc.subject.keywordAuthor | focal adhesion kinases | - |
dc.subject.keywordAuthor | placental growth factor-1 | - |
dc.subject.keywordPlus | ENDOTHELIAL-GROWTH-FACTOR | - |
dc.subject.keywordPlus | CELLS IN-VITRO | - |
dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
dc.subject.keywordPlus | INHIBITS ANGIOGENESIS | - |
dc.subject.keywordPlus | TUMOR-GROWTH | - |
dc.subject.keywordPlus | CANCER-CELLS | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | CLASS-3 SEMAPHORINS | - |
dc.subject.keywordPlus | SIGNALING PATHWAYS | - |
dc.subject.keywordPlus | PROGENITOR CELLS | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.